Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-26 @ 2:31 AM
NCT ID:
NCT02799602
Group ID:
EG000
Title:
Darolutamide (BAY1841788) + Docetaxel
Description:
Participants received darolutamide 600 mg (2 tablets of 300 mg) twice daily with food, equivalent to a total daily dose of 1200 mg in addition to their standard treatment with docetaxel and androgen deprivation therapy (ADT). Docetaxel was administered for six cycles after randomization. The first cycle of docetaxel was administered within 6 weeks after start of study drug. ADT administration started \<=12 weeks before randomization.
Deaths Number Affected:
231
Deaths Number At Risk:
None
Serious Number Affected:
306
Serious Number At Risk:
652
Other Number Affected:
636
Other Number At Risk:
652
Study:
NCT02799602
Results Section:
NCT02799602
Adverse Events Module:
NCT02799602